HCP, Inc. (HCP) Issues FY17 Earnings Guidance
HCP, Inc. (NYSE:HCP) issued an update on its FY17 earnings guidance on Thursday morning. The company provided EPS guidance of $1.92-1.96 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.92.
HCP (NYSE:HCP) last announced its quarterly earnings data on Monday, October 30th. The real estate investment trust reported $0.48 earnings per share (EPS) for the quarter, beating the consensus estimate of $0.17 by $0.31. The business had revenue of $454.00 million for the quarter, compared to the consensus estimate of $440.60 million. HCP had a net margin of 32.16% and a return on equity of 9.96%. The company’s quarterly revenue was down 14.4% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.72 earnings per share.
The company also recently disclosed a quarterly dividend, which will be paid on Tuesday, November 21st. Investors of record on Monday, November 6th will be paid a dividend of $0.37 per share. This represents a $1.48 annualized dividend and a dividend yield of 5.73%. The ex-dividend date of this dividend is Friday, November 3rd. HCP’s payout ratio is 102.07%.
Several brokerages recently issued reports on HCP. Goldman Sachs Group, Inc. (The) downgraded shares of HCP from a buy rating to a neutral rating and reduced their price objective for the company from $35.00 to $32.00 in a research note on Monday, July 24th. Stifel Nicolaus reissued a hold rating and set a $31.00 price objective on shares of HCP in a research note on Friday, July 14th. BidaskClub downgraded shares of HCP from a hold rating to a sell rating in a research note on Thursday, July 27th. KeyCorp reissued a hold rating on shares of HCP in a research note on Sunday, September 17th. Finally, Morgan Stanley reduced their price objective on shares of HCP from $31.00 to $29.00 and set an equal weight rating on the stock in a research note on Monday, September 25th. Four research analysts have rated the stock with a sell rating, thirteen have given a hold rating and one has issued a buy rating to the stock. The company presently has a consensus rating of Hold and an average price target of $30.98.
HCP Company Profile
HCP, Inc is a self-administered real estate investment trust. The Company invests in real estate serving the healthcare industry in the United States. The Company’s segments include senior housing triple-net (SH NNN), senior housing operating portfolio (SHOP), life science and medical office. Its senior housing facilities include independent living facilities, assisted living facilities, memory care facilities, care homes, and continuing care retirement communities.
Receive News & Ratings for HCP Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HCP Inc. and related companies with MarketBeat.com's FREE daily email newsletter.